Patents by Inventor Tiziana Parasassi

Tiziana Parasassi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
    Publication number: 20230226009
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Application
    Filed: September 8, 2022
    Publication date: July 20, 2023
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga, Thomas Lundeberg
  • COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
    Publication number: 20220110907
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga
  • Combination comprising N-acetyl-L-cysteine and its use
    Patent number: 11207287
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: December 28, 2021
    Assignee: IASOMAI AB
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga
  • COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
    Publication number: 20190298680
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Application
    Filed: May 2, 2019
    Publication date: October 3, 2019
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga
  • Combination comprising N-acetyl-L-cysteine and its use
    Patent number: 10300038
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: May 28, 2019
    Assignee: IASOMAI AB
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga
  • COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
    Publication number: 20180036276
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Application
    Filed: October 23, 2017
    Publication date: February 8, 2018
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga
  • Combination comprising N-acetyl-L-cysteine and its use
    Patent number: 9795582
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: October 24, 2017
    Assignee: IASOMAI AB
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga
  • N-acetyl-L-cysteine for use in in vitro fertilization
    Patent number: 9585854
    Abstract: The invention relates to a new use of NAC in IVF, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in IVF is proposed.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: March 7, 2017
    Assignee: IASOMAI AB
    Inventors: Thomas Lundeberg, Tiziana Parasassi, Eugenia Pittaluga, Roberto Brunelli
  • N-ACETYL-L-CYSTEINE FOR USE IN IN VITRO FERTILIZATION
    Publication number: 20150283103
    Abstract: The invention relates to a new use of NAC in IVF, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in IVF is proposed.
    Type: Application
    Filed: November 6, 2013
    Publication date: October 8, 2015
    Applicant: IASOMAI AB
    Inventors: Thomas Lundeberg, Tiziana Parasassi, Eugenia Pittaluga, Roberto Brunelli
  • NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
    Publication number: 20140030307
    Abstract: A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent.
    Type: Application
    Filed: September 30, 2013
    Publication date: January 30, 2014
    Applicant: IASOMAI AB
    Inventors: Tiziana Parasassi, Graziella Costa, Ewa Krasnowska, Eugenia Pittaluga
  • N-acetyl-L-cysteine for the treatment of endometriosis
    Patent number: 8637573
    Abstract: The invention relates to a new prescription of NAC in the treatment of endometriosis and of indications associated with endometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of endometriosis is proposed. In one embodiment of the present invention the prescribed treatment regimen may be used e.g. in order to control the frequency and the intensity of pain symptoms (dysmenorrhea, dyspareunia and acyclic chronic pelvic pain), to reduce the size of endometriotic lesions eventually up to their disappearance, to reduce recurrences after surgery and/or to improve fertility. Side effects of this treatment are virtually absent and, in particular, this treatment does not hinder pregnancy.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: January 28, 2014
    Assignee: Iasomai AB
    Inventors: Tiziana Parasassi, Maria Grazia Porpora
  • N-ACETYL-L-CYSTEINE FOR THE TREATMENT OF ENDOMETRIOSIS
    Publication number: 20120238627
    Abstract: The invention relates to a new prescription of NAC in the treatment of endometriosis and of indications associated with endometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of endometriosis is proposed. In one embodiment of the present invention the prescribed treatment regimen may be used e.g. in order to control the frequency and the intensity of pain symptoms (dysmenorrhea, dyspareunia and acyclic chronic pelvic pain), to reduce the size of endometriotic lesions eventually up to their disappearance, to reduce recurrences after surgery and/or to improve fertility. Side effects of this treatment are virtually absent and, in particular, this treatment does not hinder pregnancy.
    Type: Application
    Filed: March 23, 2012
    Publication date: September 20, 2012
    Applicant: IASOMAI AB
    Inventors: Tiziana Parasassi, Maria Grazia Porpora